Crinetics Pharmaceuticals, Inc. (CRNX)
55.99
-0.44
(-0.78%)
USD |
NASDAQ |
Jan 16, 16:00
55.99
0.00 (0.00%)
After-Hours: 05:59
Crinetics Pharmaceuticals Total Assets (Quarterly): 1.196B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 1.362B |
| GT Biopharma, Inc. | 4.321M |
| Axsome Therapeutics, Inc. | 669.25M |
| Sutro Biopharma, Inc. | 209.66M |
| Gossamer Bio, Inc. | 208.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 123.86M |
| Shareholders Equity (Quarterly) | 1.072B |
| Debt to Equity Ratio | 0.0458 |
| Current Ratio | 15.12 |
| Net Debt Paydown Yield | 0.02% |